We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$42.1B
AUM Growth
-$7.13B
Cap. Flow
+$617M
Cap. Flow %
1.47%
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$209M
2
T icon
AT&T
T
+$156M
3
XOM icon
ExxonMobil
XOM
+$122M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
WMT icon
Walmart Inc
WMT
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 18.92%
3 Financials 13.22%
4 Consumer Discretionary 8.69%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCCC icon
2126
C4 Therapeutics
CCCC
$376M
$19K ﹤0.01%
2,560
-25,793
-91% -$227K
FDMT icon
2127
4D Molecular Therapeutics
FDMT
$526M
$19K ﹤0.01%
2,680
HYLN icon
2128
Hyliion Holdings
HYLN
$663M
$19K ﹤0.01%
6,030
SGMO
2129
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$19K ﹤0.01%
4,590
DNUT icon
2130
Krispy Kreme
DNUT
$543M
$18K ﹤0.01%
1,310
HOV icon
2131
Hovnanian Enterprises
HOV
$785M
$18K ﹤0.01%
420
STEP icon
2132
StepStone Group
STEP
$3.48B
$18K ﹤0.01%
700
SGHT icon
2133
Sight Sciences
SGHT
$267M
$17K ﹤0.01%
1,910
CCRN
2134
DELISTED
Cross Country Healthcare
CCRN
$16K ﹤0.01%
790
ATEC icon
2135
Alphatec Holdings
ATEC
$1.27B
$14K ﹤0.01%
2,140
DENN
2136
DELISTED
Denny's
DENN
$14K ﹤0.01%
1,620
HYFM icon
2137
Hydrofarm Holdings
HYFM
$3.13M
$14K ﹤0.01%
397
IMVT icon
2138
Immunovant
IMVT
$8.09B
$14K ﹤0.01%
3,680
TMCI icon
2139
Treace Medical Concepts
TMCI
$259M
$13K ﹤0.01%
900
FLACW
2140
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$13K ﹤0.01%
150,000
ALXO icon
2141
ALX Oncology
ALXO
$273M
$11K ﹤0.01%
1,350
-126,082
-99% -$1.37M
CPRX
2142
DELISTED
Catalyst Pharmaceutical
CPRX
$10K ﹤0.01%
+1,420
New +$10.4K
DRVN icon
2143
Driven Brands
DRVN
$2.25B
$9K ﹤0.01%
340
ACCD
2144
DELISTED
Accolade Inc
ACCD
$9K ﹤0.01%
1,170
ARVL
2145
DELISTED
Arrival Ordinary Shares
ARVL
$9K ﹤0.01%
110
LEG icon
2146
Leggett & Platt
LEG
$1.52B
$8K ﹤0.01%
220
ORMP icon
2147
Oramed Pharmaceuticals
ORMP
$165M
$8K ﹤0.01%
1,760
DNA.WS
2148
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$8K ﹤0.01%
16,100
RLMD icon
2149
Relmada Therapeutics
RLMD
$544M
$7K ﹤0.01%
360
SGFY
2150
DELISTED
Signify Health, Inc.
SGFY
$7K ﹤0.01%
480

Similar funds

Ensign Peak Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
  • Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
  • Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
  • Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
  • Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
  • Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.